Patents Examined by Katherine Salmon
  • Patent number: 7407804
    Abstract: This invention relates to isolated nucleic acids comprising genes of human chromosome 12q23-qter and the proteins encoded by these genes. Expression vectors and host cells containing such genes or fragments thereof, as well as antibodies to the proteins encoded by these nucleic acids are also included herein.
    Type: Grant
    Filed: December 22, 2003
    Date of Patent: August 5, 2008
    Assignee: Oscient Pharmaceuticals Corporation
    Inventors: Tim Keith, Randall Little, Paul Van Eerdewegh, Josée Dupuis, Richard Del Mastro, Jason Simon, Kristina Allen, Sunil Pandit
  • Patent number: 7354712
    Abstract: In one aspect, the present invention provides methods of determining susceptibility to bone fracture in a mammalian subject, wherein the methods comprise analyzing nucleic acid molecules obtained from the mammalian subject to determine which of the P, p X, and x alleles of the estrogen receptor ? gene are present, wherein the presence of a haplotype comprising the p and x alleles is indicative of an increased susceptibility to bone fracture. The present invention also provides kits for determining susceptibility to bone fracture in a mammalian subject.
    Type: Grant
    Filed: June 19, 2003
    Date of Patent: April 8, 2008
    Assignee: Century Technology, Inc.
    Inventors: Andreas Gerardus Uitterlinden, Johannes Petrus Thomas Maria Van Leeuwen, Huibert Adriaan Pieter Pols
  • Patent number: 7312070
    Abstract: The present invention relates to a ?-catenin oligonucleotide microchip for detecting mutation in the mutational hot spot regions of ?-catenin gene, a manufacturing process thereof and a method for detecting the ?-catenin mutation employing same, wherein specific oligonucleotides are selectively designed to detect various missense mutations and in-frame deletion at the mutational hot spots of ?-catenin gene. The ?-catenin oligo chip of the present invention can be used in studies to detect ?-catenin mutations and unravel the signal transduction mechanism and tumorigenesis related to ?-catenin gene.
    Type: Grant
    Filed: September 9, 2003
    Date of Patent: December 25, 2007
    Assignee: National Cancer Center
    Inventors: Jae-Gahb Park, Il-Jin Kim, Hio-Chung Kang, Jae-Hyun Park
  • Patent number: 7288642
    Abstract: Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as are sulfotransferase allozymes. Methods for determining the sulfonator status of a subject also are described. In addition, methods for predicting the therapeutic efficacy of a compound in a subject are described, as are methods for estimating the dose of a compound to be administered to a subject.
    Type: Grant
    Filed: November 6, 2003
    Date of Patent: October 30, 2007
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Bianca A. Thomae, Eric D. Wieben, Richard M. Weinshilboum
  • Patent number: 7288641
    Abstract: Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as sulfotransferase allozymes. Methods for determining if a mammal is predisposed to cancer also are described.
    Type: Grant
    Filed: January 30, 2003
    Date of Patent: October 30, 2007
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Araba A. Adjei, Eric D. Wieben, Richard M. Weinshilboum, Bianca A. Thomae
  • Patent number: 7270957
    Abstract: Bacteria that are capable of ammonia oxidation. Particular bacteria of the present invention are tolerant of freshwater environments, saltwater environments or both. Furthermore, in various embodiments, various bacteria of the present invention are capable of surviving a freeze-drying process, and may remain viable thereafter. Methods for detecting the bacteria of the present invention are also provided. Such methods may be effected by any conventional methology, such as with a DNA chip.
    Type: Grant
    Filed: September 10, 2003
    Date of Patent: September 18, 2007
    Assignee: Aquaria, Inc.
    Inventor: Timothy A. Hovanec
  • Patent number: 7241566
    Abstract: A method for detecting a Salmonella species, E. coli O157:H7, or Listeria monocytogenes is disclosed. The method involves amplifying a genomic nucleotide sequence of a corresponding species and detecting the amplification product. Various primers and probes that can be used in the method are also disclosed. In one embodiment, the amplification step of the method is accomplished by real-time PCR and the amplification product is detected by fluorescence resonance energy transfer using a pair of labeled polynucleotides.
    Type: Grant
    Filed: June 21, 2002
    Date of Patent: July 10, 2007
    Assignee: Marshfield Clinic
    Inventors: Jay L. E. Ellingson, Dirk N. Vevea
  • Patent number: 7101666
    Abstract: Methods and kits for determining susceptibility of a patient to mood disorders are described. The method involves analyzing a sample comprising nucleic acids from a patient for a polymorphism in the promoter region of the BDNF gene.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: September 5, 2006
    Assignee: Centre for Addiction and Mental Health
    Inventors: James Lowery Kennedy, Fabio Macciardi